Evidence map›Paper›PMID 37128329›Full record

ArticleHeliyon2023

The Chinese media narrative of Thailand as a tourist destination after the legalisation of cannabis.

Shuang Deng, Pavel Slutskiy, Smith Boonchutima

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shuang DengStrategic Communication Management Program, Faculty of Communication Arts, Chulalongkorn University, Bangkok, Thailand.
Pavel SlutskiyResearch Unit on Communication Innovation for Development of Quality of Life and Sustainability, Faculty of Communication Arts, Chulalongkorn University, Bangkok, Thailand.
Smith BoonchutimaResearch Unit on Communication Innovation for Development of Quality of Life and Sustainability, Department of Public Relations, Faculty of Communication Arts, Chulalongkorn University, Bangkok, Thailand.
Chulalongkorn University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the Chinese media narrative of Thailand as a tourist destination after Thailand legalised cannabis use for medicinal purposes, using framing and social identity theories. A content analysis was performed by three coders on 128 posts obtained between 2019 and 2022 from four media houses on the Chinese social media platform Weibo: Taiguo.com, Taihuabbs, Vision Thai, and The Sing Sian Media. The first three are Chinese media houses, and the fourth is a Chinese-language newspaper in Bangkok. The results revealed that the Chinese media's framing of the legalisation of cannabis use in Thailand was mainly neutral. In contrast, Chinese netizens' comments showed a negative perception of Thailand as a travel destination after the legalisation of cannabis use. In addition, the study identified the different themes and aspects of narrating, news sources, and media types used to present the information. The implications of these findings highlight the need for the Thai government to develop effective policies and communication strategies to address negative perceptions and promote Thailand as a safe and attractive destination for tourists. The study also suggests the importance of considering cultural and social factors when crafting communication strategies, particularly for sensitive topics such as cannabis use.

Indexed as

CannabisChinese mediaFraming theorySocial identity theoryThailandTourism

Identifiers

PMID37128329
PMCPMC10148097
OpenAlexW4365504865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.